eNavvi Expands Nationwide Compound Pharmacy Network, Invites Accredited Pharmacy Partners

eNavvi Expands Nationwide Compound Pharmacy Network, Invites Accredited Pharmacy Partners News provided by eNavvi Jul 21, 2025, 09:00 ET Share this article Share to X Share this article Share to X Physician-built platform lets U.S. clinicians prescribe vetted, FDA-compliant compounded medications in under 60 seconds, explicitly blocking unapproved products like compounded semaglutide or tirzepatide. SAN JOSE, Calif. , July 21, 2025 /PRNewswire/ -- eNavvi , the cash‑pay digital prescribing platform founded by physicians, today announced the launch of its All‑Specialty Compound Medication Marketplace and a formal call for additional accredited compounding pharmacies to join its network. For clinicians, the new release means one login to browse pricing and send digital prescription orders for 150 + pre‑formulated compounds and growing. For pharmacy owners, it offers turnkey access to a rapidly growing prescriber base across the entire country. What Doctors Can Prescribe Today Dermatology Tretinoin 0.05 % / Hydroquinone 6 % Cream – acne & dyspigmentation Minoxidil 5 % / Finasteride 0.1 % Topical Solution – androgenic alopecia Clobetasol 0.05 % / Salicylic Acid 3 % Ointment – plaque psoriasis Gastroenterology Nifedipine 0.2 % / Lidocaine 5 % Rectal Cream – anal fissures / hemorrhoids Urology & Men's Health Sildenafil 40 mg Sublingual Troche – erectile dysfunction with rapid onset Pain & Neurology Ketoprofen 10 % / Gabapentin 6 % / Cyclobenzaprine 2 % Cream – neuropathic & myofascial pain "Compounded medications are indispensable for truly personalized care yet ordering them has been mired in fax workflows," said Alex Prevallet, DO, Chief Growth Officer at eNavvi . "We built eNavvi so any clinician—derm, pain, GI, you name it—can click, confirm, and send in under a minute while keeping patients' out‑of‑pocket costs transparent." Built‑In Safeguards & Compliance FDA alignment: eNavvi blocks NDCs and APIs identified on FDA's Bulk Drug Substances List of concern; no compounded GLP‑1 agents (e.g., semaglutide, tirzepatide) are available. Vetted partners: Pharmacies must hold multi-state licenses and hold PCAB or NABP Accreditation. HIPAA‑secure workflow: End‑to‑end encryption, SOC 2‑aligned controls, and direct EPCS support planned for Q4 2025. Invitation to Compound Pharmacies eNavvi is actively onboarding additional 503‑A and 503‑B pharmacies that can: Demonstrate sterile or non‑sterile USP compliance with recent QA audits. Provide transparent, national pricing for cash‑pay scripts. Integrate via API for digital prescription routing. Interested pharmacies may apply at [email protected] . Immediate Access for Prescribers Clinicians can start prescribing compounded therapies today—no subscription fees, no credit card required—via: Web: https://enavvi.com/results/CompoundDrugs?condition=1 iOS: Search "eNavvi" in the App Store. About eNavvi eNavvi is a physician‑founded digital prescription pad built to make cash‑pay medications affordable and hassle‑free. The platform connects thousands of verified prescribers to a growing nationwide network of pharmacies, delivering price transparency resulting in patient savings compared with retail cash prices. Learn more at www.enavvi.com . Media Contact Teja Pathakota, MD, MBA Chief Financial Officer, eNavvi Inc. [email protected] SOURCE eNavvi 21 % more press release views with Request a Demo × Modal title